Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods.
Castro, Felipe A; Koshiol, Jill; Quint, Wim; Wheeler, Cosette M; Gillison, Maura L; Vaughan, Laurence M; Kleter, Bernhard; van Doorn, Leen-Jan; Chaturvedi, Anil K; Hildesheim, Allan; Schiffman, Mark; Wang, Sophia S; Zuna, Rosemary E; Walker, Joan L; Dunn, S Terence; Wentzensen, Nicolas.
BMC Infect Dis
; 15: 544, 2015 Nov 25.
Artigo em Inglês | MEDLINE | ID: mdl-26607224
Comparative evaluation of the Omniplex-HPV and RFMP HPV PapilloTyper for detecting human papillomavirus genotypes in cervical specimens.
Guidance on liquid-based cytology system conversion training: a secondary publication.
Cytology versus HPV testing for cervical cancer screening in the general population.
Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework.
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study.
Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance.
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions.
Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.